MONICA PATEL: Open Payments
NPI 1508620261 · SOMERDALE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $747
Food & beverage: $675Education: $72
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $333 |
| Janssen Biotech, Inc. | 5 | $200 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| ABBVIE INC. | 2 | $40 |
| GENZYME CORPORATION | 1 | $34 |
| Organon LLC | 1 | $20 |
| Biofrontera Inc. | 1 | $17 |
| UCB, Inc. | 1 | $15 |
Products named: OPZELURA, TREMFYA, DUPIXENT, SKYRIZI, Bimzelx.
Industry payments across NJ — which companies pay providers there.
